12-120
Showing 1 - 25 of >10,000
Phenotype of Headache and Facial Pain in Upper Respiratory Tract
Not yet recruiting
- Upper Respiratory Tract Infections
- Swab test for viral antigens
-
Dzwierzuty, Warmińsko-mazurskie, PolandMarcin Straburzyński
Nov 9, 2023
Migraine in Poland - a Web-based Cross-sectional Survey
Completed
- Migraine
-
Dzwierzuty, Warmińsko-mazurskie, Poland
- +1 more
May 3, 2022
KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)
Recruiting
- KRAS P.G12C
- Non Small Cell Lung Cancer
- Sotorasib 120Mg Tab
-
Lyon, France
- +3 more
Dec 16, 2022
Helicobacter Pylori Infection, Dysbiosis, Probiotics Trial in Tainan (Bismuth Subcitrate 120 MG Oral Tablet, Lactobacillus
Enrolling by invitation
- Helicobacter Pylori Infection
- +2 more
- Bismuth Subcitrate 120 MG Oral Tablet
- +4 more
-
Tainan, TaiwanHelicobacter pylori study group, National Cheng Kung University
Jul 17, 2022
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Trial in Worldwide (Triheptanoin, MCT Oil)
Recruiting
- Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
- Triheptanoin
- MCT Oil
-
Prague, Czechia
- +12 more
Jul 11, 2023
Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (AG-120, Placebo)
Completed
- Advanced Cholangiocarcinoma
- Metastatic Cholangiocarcinoma
- AG-120
- Placebo
-
Scottsdale, Arizona
- +48 more
Dec 20, 2022
Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation
Recruiting
- Alzheimer Disease
- +34 more
- Sensory Stimulation System (GS120) - Active
- Sensory Stimulation System (GS120) - Sham
-
Washington, District of Columbia
- +24 more
Jan 27, 2023
Guide Experimental Targeted Therapy - National
Recruiting
- Cancer
-
Belfast, United Kingdom
- +19 more
Aug 23, 2022
Meningococcal Vaccine Trial in Germany, Greece, Spain (biological, drug, other)
Active, not recruiting
- Meningococcal Vaccine
- MenABCWY
- +8 more
-
Mannheim, Germany
- +20 more
Jun 28, 2022
Pancreatic Tumours, Midgut Neuroendocrine Tumours Trial in Worldwide (Lanreotide autogel 120 mg)
Completed
- Pancreatic Tumours
- Midgut Neuroendocrine Tumours
- Lanreotide autogel 120 mg
-
Bruxelles, Belgium
- +31 more
Dec 4, 2020
Olaparib Real-world Utilization and Clinical Outcomes in France,
Active, not recruiting
- Ovary Cancer
-
Saint Pierre, La Réunion (oversea France), France
- +51 more
Jan 23, 2023
Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (E7050, Cetuximab)
Completed
- Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
-
Tucson, Arizona
- +22 more
Dec 3, 2021
Overactive Bladder Trial in Worldwide (Placebo, BAY1817080)
Completed
- Overactive Bladder
- Placebo
- BAY1817080
-
Botany, New South Wales, Australia
- +27 more
Feb 9, 2022
Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,
Active, not recruiting
- Locally Advanced or Metastatic Medullary Thyroid Cancer
- Medullary Thyroid Cancer
- Patient outreach
- Vandetanib
-
St Leonards, Australia
- +33 more
Oct 20, 2021
Congenital Heart Disease (CHD) Trial in Canada, United States (Umbilical Cord Clamping at ~30 seconds, Umbilical Cord Clamping
Not yet recruiting
- Congenital Heart Disease (CHD)
- Umbilical Cord Clamping at ~30 seconds
- +2 more
-
Birmingham, Alabama
- +20 more
Nov 22, 2023
Primary Biliary Cholangitis Trial in Worldwide (Obeticholic acid, Bezafibrate 200 MG, OCA Placebo)
Recruiting
- Primary Biliary Cholangitis
- Obeticholic acid
- +5 more
-
Bedford Park, Perth, Australia
- +67 more
Dec 2, 2022
Carotid Stenosis, Atherosclerosis, Stroke Trial in Germany, United Kingdom (Revacept, Placebo)
Malignant Melanoma Trial in Worldwide (Atezolizumab, Cobimetinib)
Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Combined Hepatocellular and Cholangiocarcinoma
-
Phoenix, Arizona
- +40 more
Mar 7, 2022
Ovary Cancer, Stage II-IV, Quality of Life, Depressive Symptoms Trial (POSTCare Survivorship transition process)
Not yet recruiting
- Ovary Cancer, Stage II-IV
- +2 more
- POSTCare Survivorship transition process
- (no location specified)
Feb 22, 2023